Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1996 1
2000 1
2004 1
2005 1
2009 2
2010 2
2011 2
2012 2
2013 2
2014 2
2015 2
2016 2
2017 1
2018 2
2019 2
2020 1
2021 2
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Recent trends in the management of minor salivary gland carcinoma.
Vander Poorten V, Hunt J, Bradley PJ, Haigentz M Jr, Rinaldo A, Mendenhall WM, Suarez C, Silver C, Takes RP, Ferlito A. Vander Poorten V, et al. Head Neck. 2014 Mar;36(3):444-55. doi: 10.1002/hed.23249. Epub 2013 Apr 4. Head Neck. 2014. PMID: 23559518 Review.
Minor Salivary Gland Carcinoma of the Oropharynx: A Population-Based Analysis of 1426 Patients.
Goel AN, Badran KW, Braun APG, Garrett AM, Long JL. Goel AN, et al. Otolaryngol Head Neck Surg. 2018 Feb;158(2):287-294. doi: 10.1177/0194599817735309. Epub 2017 Oct 3. Otolaryngol Head Neck Surg. 2018. PMID: 28971745
Five- and 10-year rates of disease-specific survival were 75.1% and 61.6%, respectively. Independent prognostic factors included tumor grade, T stage, N stage, and age >70 years. Conclusions This study represents the largest multivariate survival analysis of MSGC of the …
Five- and 10-year rates of disease-specific survival were 75.1% and 61.6%, respectively. Independent prognostic factors included tumo …
Salivary gland polymorphous adenocarcinoma: Clinicopathological features and gene alterations in 36 Japanese patients.
Fukumura M, Ishibashi K, Nakaguro M, Nagao T, Saida K, Urano M, Tanigawa M, Hirai H, Yagyuu T, Kikuchi K, Yada N, Sugita Y, Miyabe M, Hasegawa S, Goto M, Yamamoto H, Ohuchi T, Kusafuka K, Ogawa I, Suzuki H, Notohara K, Shimoda M, Tada Y, Kirita T, Takata T, Morinaga S, Maeda H, Warnakulasuriya S, Miyabe S, Nagao T. Fukumura M, et al. J Oral Pathol Med. 2022 Sep;51(8):710-720. doi: 10.1111/jop.13336. Epub 2022 Aug 15. J Oral Pathol Med. 2022. PMID: 35880805
Additionally, we applied a SNaPshot multiplex assay to identify PRKD1 hotspot mutations. RESULTS: This study revealed the indolent clinical course of polymorphous adenocarcinoma with a high 10-year overall survival rate (92.9%), accompanied by occasional local recurrences …
Additionally, we applied a SNaPshot multiplex assay to identify PRKD1 hotspot mutations. RESULTS: This study revealed the indolent clinical …
Minor salivary gland carcinoma: a review of 35 cases.
Haymerle G, Schneider S, Harris L, Häupl T, Schopper C, Pammer J, Grasl MCh, Erovic BM. Haymerle G, et al. Eur Arch Otorhinolaryngol. 2016 Sep;273(9):2717-26. doi: 10.1007/s00405-015-3805-4. Epub 2015 Oct 23. Eur Arch Otorhinolaryngol. 2016. PMID: 26498950
We have shown that Smo resulted in a better overall survival, whereas Gstpi in improved disease-free survival. VEGFR2 was a prognostic factor for survival after recurrence in patients with minor salivary gland carcinomas. ...
We have shown that Smo resulted in a better overall survival, whereas Gstpi in improved disease-free survival. VEGFR2 was a prognostic
ELMO3 - a Negative Prognostic Marker in Minor Salivary Gland Carcinoma.
Kotowski U, Kadletz L, Schneider S, Oberndorfer F, Erovic BM, Grasl MC, Lill C, Heiduschka G. Kotowski U, et al. Pathol Oncol Res. 2019 Apr;25(2):585-591. doi: 10.1007/s12253-018-0475-8. Epub 2018 Oct 29. Pathol Oncol Res. 2019. PMID: 30374620 Free PMC article.
High staining intensity of ELMO3 correlated with a significantly worse disease free survival (p = .0495) and a higher recurrence rate (p = .0071). In conclusion, it is still difficult to predict the clinical outcome of patients with minor salivary gland carcinoma. Evaluati …
High staining intensity of ELMO3 correlated with a significantly worse disease free survival (p = .0495) and a higher recurrence rate (p = . …
Lymph node ratio as a predictor for minor salivary gland cancer in head and neck.
Suzuki H, Sasaki E, Takano G, Goto S, Nishikawa D, Beppu S, Terada H, Sawabe M, Hanai N. Suzuki H, et al. BMC Cancer. 2021 Nov 6;21(1):1186. doi: 10.1186/s12885-021-08877-3. BMC Cancer. 2021. PMID: 34742280 Free PMC article.
RESULTS: Lymph node ratio = 0.05 as well as log odds of positive lymph nodes = - 2.73 predicted the carcinoma-specific death. Both lymph node ratio and log odds of positive lymph nodes were significantly related with survival outcomes by the univariate analysis. ...CONCLUS …
RESULTS: Lymph node ratio = 0.05 as well as log odds of positive lymph nodes = - 2.73 predicted the carcinoma-specific death. Both ly …
Prediction of Minor Salivary Gland Carcinoma: A Novel Nomogram and Risk Classification System for Overall Survival and Cancer-Specific Survival.
Lan LF, Gao CK, Ma CW. Lan LF, et al. Otolaryngol Head Neck Surg. 2021 Feb;164(2):359-368. doi: 10.1177/0194599820938323. Epub 2020 Jul 21. Otolaryngol Head Neck Surg. 2021. PMID: 32692284
The concordance index for internal validation of OS and CSS prediction was 0.842 and 0.816; that of external validation was 0.871 and 0.831. The calibration plots showed good consistency between nomogram prediction and actual survival. The decision curve analysis sh …
The concordance index for internal validation of OS and CSS prediction was 0.842 and 0.816; that of external validation was 0.871 and …
Malignant minor salivary gland carcinomas of the larynx.
Zhang M, Li KN, Li C, Zhou L, Zhu JX, Wang SY. Zhang M, et al. ORL J Otorhinolaryngol Relat Spec. 2014;76(4):222-6. doi: 10.1159/000368322. Epub 2014 Nov 13. ORL J Otorhinolaryngol Relat Spec. 2014. PMID: 25401372
Wide-margin surgery with postoperative radiotherapy is advocated. The overall prognosis is poor compared to squamous cell carcinomas of the same location and tumour stage....
Wide-margin surgery with postoperative radiotherapy is advocated. The overall prognosis is poor compared to squamous cell carcinomas …
Long-term treatment outcome of minor salivary gland carcinoma of the hard palate.
Li Q, Zhang XR, Liu XK, Liu ZM, Liu WW, Li H, Guo ZM. Li Q, et al. Oral Oncol. 2012 May;48(5):456-62. doi: 10.1016/j.oraloncology.2011.12.005. Epub 2012 Jan 16. Oral Oncol. 2012. PMID: 22248739
Minor salivary gland carcinoma of the hard palate is rare, and its long-term survival rate is high, making it difficult to evaluate the prognostic factors and the efficacy of treatment. This study was designed to evaluate the treatment outcome of minor salivary gland carci …
Minor salivary gland carcinoma of the hard palate is rare, and its long-term survival rate is high, making it difficult to evaluate the p
25 results